Stem Cell Advocates and Critics Push Back on FDA Guidelines

Editor’s Note (9/22/2016): This article has been updated from the original to include the location of the hearing and a response from physicians involved in a stem cell treatment study. Earlier this month the U.S. Food and Drug Administration opened its doors to public commentary on its newest guidelines on the use of therapies derived